	US 12,247,032 B2
	Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of JAK kinases
Mark Edward Zak, Davidsonville, MD (US); Naomi S. Rajapaksa, San Mateo, CA (US); Yun-Xing Cheng, Beijing (CN); Jessica Grandner, San Mateo, CA (US); Daniel G. M. Shore, Redwood City, CA (US); F. Anthony Romero, Redwood City, CA (US); and Marian C. Bryan, Fort Washington, PA (US)
Assigned to Genentech, Inc., South San Francisco, CA (US)
Filed by Genentech, Inc., South San Francisco, CA (US)
Filed on Dec. 8, 2022, as Appl. No. 18/063,575.
Application 18/063,575 is a continuation of application No. 16/902,490, filed on Jun. 16, 2020, abandoned.
Claims priority of provisional application 63/036,046, filed on Jun. 8, 2020.
Claims priority of application No. PCT/CN2019/091709 (WO), filed on Jun. 18, 2019.
Prior Publication US 2023/0167123 A1, Jun. 1, 2023
Int. Cl. A61P 37/06 (2006.01); C07D 487/04 (2006.01)

CPC C07D 487/04 (2013.01) [A61P 37/06 (2018.01)]

1 Claim

1. A compound selected from the group consisting of:

or a pharmaceutically acceptable salts thereof.